Independent report
Child-family screening for familial hypercholesterolemia: ethical issues
An analysis of the ethical issues raised by child-family cascade screening for familial hypercholesterolemia (FH).
Documents
Details
In 2020, the UK National Screening Committee (UK NSC) set up an ethics task group to carry out an analysis of the ethical issues raised by child-family cascade screening for familial hypercholesterolemia (FH). The group included members with expertise in ethics, paediatrics, clinical genetics, sociology, primary care and public health and a patient representative.
Updates to this page
Published 10 February 2022